• Alzheimer's Treatment

  • Sep 11 2024
  • Length: 7 mins
  • Podcast

  • Summary

  • Alzheimer’s disease is the most common cause of major neurocognitive disorder and and while largely managed with non-pharmacologic interventions, there are also a variety of pharmacotherapeutics available for use when appropriate. Which of the following is considered a first-line pharmacologic intervention for symptom control in the patient with Alzheimer’s disease?

    A. Lecanemab

    B. Donepezil

    C. Memantine

    D. Namzaric®
    ---
    YouTube: https://www.youtube.com/watch?v=-z2D99MLGuM&list=PLf0PFEPBXfq5HGfNV-GbOlYHtDwd35OeG&index=34

    Show more Show less

What listeners say about Alzheimer's Treatment

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.